Stock 1SXP SCHOTT PHARMA AG & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases SCHOTT Pharma AG & Co. KGaA

Equities

1SXP

DE000A3ENQ51

Market Closed - Xetra
Other stock markets
 11:35:11 2024-06-06 am EDT 		After market 12:17:26 pm
28.06 EUR -0.43% Intraday chart for SCHOTT Pharma AG & Co. KGaA 28.14 +0.29%
Jun. 05 SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion CI
May. 28 SCHOTT PHARMA : Berenberg reiterates its Neutral rating ZD

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Simplifying Subcutaneous Drug Administration, SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
AQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes
EQ
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes
EQ
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina
AQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQ
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQ
DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell
EQ
SCHOTT Pharma reports good start into fiscal year 2024
EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQ
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance
EQ
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1SXP Stock
  4. News SCHOTT Pharma AG & Co. KGaA
  5. Press Releases